Alison Marshall is an epidemiology PhD student in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Australia. Her research is primarily centered on the LiveRLife Study with specific attention to HCV and liver disease knowledge, liver disease assessment, and HCV treatment uptake.

Dr. Jason Grebely is an Associate Professor at the Kirby Institute at UNSW Sydney.

Dr. Brian Conway is the Director of the Vancouver Infectious Diseases Center in Vancouver, Canada.

Dr. Kapadia is a fellow in Infectious Diseases at Weill Cornell Medicine and a resident in the Preventive Medicine Program. He is completing a Masters' of Science degree at the Weill Cornell Graduate School. His clinical and research interest is in hepatitis C treatment access disparities.

Håvard Midgard is a MD in gastroenterology and hepatology at Oslo University Hospital. He recently submitted his PhD thesis on management of HCV infection among people who inject drugs. His research has focused on treatment utake, reinfection and risk behaviours.

Dr. Grebely is an Associate Professor in the Viral Hepatitis Clinical Research Program at the Kirby Institute of UNSW Sydney in Sydney, Australia.